Constellation Pharmaceuticals

Constellation Pharmaceuticals is the first biopharmaceutical company dedicated to the development of novel therapeutics in the emerging field of Epigenetics, a new field of science which is focused on selective regulators of epigenetic function, which are critical to controlling gene expression.
Type
Private
HQ
Cambridge, US
Founded
2008
Employees
59 (est)+4%
Constellation Pharmaceuticals was founded in 2008 and is headquartered in Cambridge, US

Key People at Constellation Pharmaceuticals

Keith Dionne

Keith Dionne

President & Chief Executive Officer
Matthias Jaffe

Matthias Jaffe

Chief Financial Officer
Mark A. Goldsmith

Mark A. Goldsmith

Executive Chairman
James Audia

James Audia

Chief Scientific Officer
Brenda Sousa

Brenda Sousa

Vice President of Human Resources
Cameron Wheeler

Cameron Wheeler

business development and operating experience

Constellation Pharmaceuticals Locations

Cambridge, US

Constellation Pharmaceuticals Metrics

Constellation Pharmaceuticals Summary

Founding Date

2008

Total Funding

$210 M

Latest funding size

$55 M

Time since last funding

about 1 year

Investors

We estimate that Constellation Pharmaceuticals's latest funding round in December 2015 was $55 M. In total, Constellation Pharmaceuticals has raised $210 M
We estimate that Constellation Pharmaceuticals's current employees are approximately 21% female and 79% male.

Constellation Pharmaceuticals Online Presence

Constellation Pharmaceuticals News

Constellation Pharmaceuticals Company Life

You may also be interested in